Abstract:Background The microRNA miR-221-3p has previously been found to be an underlying biomarker of pancreatic cancer. However, the mechanisms of miR-221-3p underlying its role in pancreatic cancer pathogenesis, proliferation capability, invasion ability, drug resistance and apoptosis and the clinicopathological value of miR-221-3p have not been thoroughly studied. Methods Based on microarray and miRNA-sequencing data extracted from Gene Expression Omnibus (GEO), The Cancer Genome Atlas (TCGA), relevant literature, and real-time quantitative PCR (RT-qPCR), we explored clinicopathological features and the expression of miR-221-3p to determine its clinical effect in pancreatic cancer. Proliferation, migration, invasion, apoptosis and in vitro cytotoxicity tests were selected to examine the roles of mir-221-3p. In addition, several miR-221-3p functional analyses were conducted, including Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) and Protein-protein interaction (PPI) network analyses, to examine gene interactions with miR-221-3p. Results The findings of integrated multi-analysis revealed higher miR-221-3p expression in pancreatic cancer tissues and blood than that in para-carcinoma samples (SMD of miR-221-3p: 1.52; 95% CI 0.96, 2.08). MiR-221-3p is related to survival both in pancreatic cancer and pancreatic ductal adenocarcinoma patients. Cell experiments demonstrated that miR-221-3p promotes pancreatic cancer cell proliferation capability, migration ability, invasion ability, and drug resistance but inhibits apoptosis. Further pancreatic cancer bioinformatics analyses projected 30 genes as the underlying targets of miR-221-3p. The genes were significantly distributed in diverse critical pathways, including microRNAs in cancer, viral carcinogenesis, and the PI3K-Akt signalling pathway. Additionally, PPI indicated four hub genes with threshold values of 5: KIT, CDKN1B, RUNX2, and BCL2L11. Moreover, cell studies showed that miR-221-3p can inhibit these four hub genes expression in pancreatic cancer. Conclusions Our research revealed that pancreatic cancer expresses a high-level of miR-221-3p, indicating a potential miR-221-3p role as a prognosis predictor in pancreatic cancer. Moreover, miR-221-3p promotes proliferation capacity, migration ability, invasion ability, and drug resistance but inhibits apoptosis in pancreatic cancer. The function of miR-221-3p in the development of pancreatic cancer may be mediated by the inhibition of hub genes expression. All these results might provide an opportunity to extend the understanding of pancreatic cancer pathogenesis.

MicroRNA-23a Acts As an Oncogene in Pancreatic Carcinoma by Targeting TFPI-2

Insight into the effects of microRNA-23a-3p on pancreatic cancer and its underlying molecular mechanism

MicroRNA-204-3p Inhibits Metastasis of Pancreatic Cancer Via Downregulating MGAT1.

MicroRNA-222 Controls Human Pancreatic Cancer Cell Line Capan-2 Proliferation by P57 Targeting.

MicroRNA-23a promotes pancreatic cancer metastasis by targeting epithelial splicing regulator protein 1.

Association of microRNA-23 b-3 p down-regulation with progression and survival in pancreatic duct adenocarcinoma and its prospective function via bioinformatics analysis

Mir-19B-3p Promotes Human Pancreatic Cancer Capan-2 Cells Proliferation by Targeting Phosphatase and Tension Homolog

MicroRNA-20a Overexpression Inhibited Proliferation and Metastasis of Pancreatic Carcinoma Cells

Down-regulation of microRNA-23a promotes pancreatic ductal adenocarcinoma initiation and progression by up-regulation of FOXM1 expression

Upregulated exosomic miR-23b-3p plays regulatory roles in the progression of pancreatic cancer

Microrna-216a Targets Wt1 Expression And Regulates Krt7 Transcription To Mediate The Progression Of Pancreatic Cancer-A Transcriptome Analysis

MicroRNA-221-3p is Related to Survival and Promotes Tumour Progression in Pancreatic Cancer: a Comprehensive Study on Functions and Clinicopathological Value

MiR-23 a promotes cell proliferation and invasion in papillary thyroid carcinoma by targeting PTEN

Microrna-148a-3p Suppresses Epithelial-To-Mesenchymal Transition And Stemness Properties Via Wnt1-Mediated Wnt/Beta-Catenin Pathway In Pancreatic Cancer

MicroRNA-375 targets the 3-phosphoinositide-dependent protein kinase-1 gene in pancreatic carcinoma.

Mir-331-3p Functions As an Oncogene by Targeting ST7L in Pancreatic Cancer.

MiR-499a-5p promotes 5-FU resistance and the cell proliferation and migration through activating PI3K/Akt signaling by targeting PTEN in pancreatic cancer

MiR-451 Promotes Cell Proliferation and Metastasis in Pancreatic Cancer Through Targeting CAB39.

MicroRNA-216b-5p Functions as a Tumor-suppressive RNA by Targeting TPT1 in Pancreatic Cancer Cells

Mir-371-5p Facilitates Pancreatic Cancer Cell Proliferation and Decreases Patient Survival

Microrna-375 Is Downregulated In Pancreatic Cancer And Inhibits Cell Proliferation In Vitro